CGNS.F Stock Overview
Operates as a technology company. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Cognetivity Neurosciences Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.003 |
| 52 Week High | CA$0.064 |
| 52 Week Low | CA$0.0011 |
| Beta | -0.22 |
| 11 Month Change | -53.13% |
| 3 Month Change | -25.00% |
| 1 Year Change | -94.12% |
| 33 Year Change | -99.36% |
| 5 Year Change | -98.12% |
| Change since IPO | -99.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| CGNS.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -70.0% | 1.5% | 2.2% |
| 1Y | -94.1% | 20.9% | 31.7% |
Return vs Industry: CGNS.F underperformed the US Medical Equipment industry which returned 21.4% over the past year.
Return vs Market: CGNS.F underperformed the US Market which returned 31.1% over the past year.
Price Volatility
| CGNS.F volatility | |
|---|---|
| CGNS.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine CGNS.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Sina Habibi | cognetivity.com |
Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd.
Cognetivity Neurosciences Ltd. Fundamentals Summary
| CGNS.F fundamental statistics | |
|---|---|
| Market cap | US$669.34k |
| Earnings (TTM) | -US$8.64m |
| Revenue (TTM) | US$98.97k |
0.0x
P/S Ratio0.0x
P/E RatioIs CGNS.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CGNS.F income statement (TTM) | |
|---|---|
| Revenue | CA$98.97k |
| Cost of Revenue | CA$1.36m |
| Gross Profit | -CA$1.27m |
| Other Expenses | CA$7.38m |
| Earnings | -CA$8.64m |
Last Reported Earnings
Oct 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.092 |
| Gross Margin | -1,278.71% |
| Net Profit Margin | -8,732.77% |
| Debt/Equity Ratio | -19.9% |
How did CGNS.F perform over the long term?
See historical performance and comparison